At-the-Market Equity Offerings (Tables)

9 Months Ended

Sep. 30, 2024

At Market Equity Offerings [Abstract]

Summary of Active At-the-Market Equity Offering

The following table summarizes the terms and provisions of each sales agreement, and pursuant to each at-the-market equity offering program that was active during the nine months ended September 30, 2024 and the year ended December 31, 2023. The maximum aggregate offering price and cumulative net proceeds (less sales commissions and expenses) for each at-the-market equity offering program in the following table are reported in thousands.

	August 2024 Sales Agreement			November 2023 Sales Agreement			August 2023 Sales Agreement			May 2023 Sales Agreement			2022 Sales Agreement
Agreement effective date	August 1, 2024			November 30, 2023			August 1, 2023			May 1, 2023			September 9, 2022
Maximum aggregate offering price	$	2,000,000		$	750,000		$	750,000		$	625,000		$	500,000
Maximum commissions payable to sales agents on gross proceeds from the sale of shares		2.0	%		2.0	%		2.0	%		2.0	%		2.0	%
Date terminated	n/a			July 31, 2024			November 29, 2023			August 1, 2023			May 1, 2023
As of September 30, 2024:
Cumulative shares sold under such sales agreement		8,048,449			12,720,770			15,929,500			10,791,700			15,674,300
Cumulative net proceeds received from shares sold under such sales agreement	$	1,105,141		$	747,025		$	737,760		$	333,494		$	385,181
Maximum aggregate offering price remaining available for sale under such sales agreement	$	891,286		n/a			n/a			n/a			n/a

Summary of Sales Activity of Sales Agreement for At-the-Market Equity Offering

The following table summarizes the sales activity of each sales agreement that was active during 2024 or 2023 for the periods indicated. The net proceeds (less sales commissions and expenses) for each at-the-market equity offering program are reported in thousands.

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Number of shares sold under such sales agreement:
2022 Sales Agreement	n/a		n/a		n/a			13,488,550
May 2023 Sales Agreement	n/a			0	n/a			10,791,700
August 2023 Sales Agreement	n/a			4,033,620	n/a			4,033,620
November 2023 Sales Agreement		0	n/a			1,951,620	n/a
August 2024 Sales Agreement		8,048,449	n/a			8,048,449	n/a
Total shares sold pursuant to at-the-market equity offering programs		8,048,449		4,033,620		10,000,069		28,313,870
Net proceeds received from shares sold under such sales agreement:
2022 Sales Agreement	n/a		n/a		n/a		$	338,962
May 2023 Sales Agreement	n/a			0	n/a			333,494
August 2023 Sales Agreement	n/a			147,218	n/a			147,218
November 2023 Sales Agreement		0	n/a			137,152	n/a
August 2024 Sales Agreement		1,105,141	n/a			1,105,141	n/a
Total net proceeds received from shares sold pursuant to at-the-market equity offering programs	$	1,105,141	$	147,218	$	1,242,293	$	819,674